UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  June 30, 2020

 

Catasys, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-31932

 

88-0464853

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

 

2120 Colorado Ave., Suite 230

Santa Monica, California

 

90404

(Address of principal executive offices)

 

(Zip Code)

     

Registrant’s telephone number, including area code   (310) 444-4300

 

(Former name or former address, if changed since last report.)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value

CATS

The NASDAQ Capital Market

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 8.01.     Other Events.

 

On June 30, 2020, Catasys, Inc. (the “Company”) issued a press release announcing the accelerated expansion of its OnTrak solution with a leading national health plan across their National Medicare Advantage business. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01.     Financial Statements and Exhibits.

 

(d)     Exhibits.

 

No.

Description

     

99.1

Press Release, dated June 30, 2020.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CATASYS, INC.

  

 

 

 

Date:  June 30, 2020

 

By:

/s/ Brandon LaVerne

 

 

 

Brandon LaVerne

 

 

 

Chief Financial Officer

 

 

Exhibit 99.1

 

 

 

News Release

For Immediate Release

 

National Health Plan Expands Catasys’ OnTrak-CI Program Across Their

National Medicare Advantage Business

 

Company’s enrollment momentum continued through June

 

Santa Monica, CA – June 30, 2020 – Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment company, today announced a three-year contract with a leading national health plan for the accelerated expansion of its OnTrak-CI solution. This nationwide, simultaneously-launched expansion ensures that eligible Medicare Advantage members of the health plan will have access to critical behavioral healthcare in an additional 13 states.

 

Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “The proven ROI and positive clinical outcomes of our OnTrak™ program in two pilot markets prompted this health plan partner to change their plans from a state-by-state rollout to a simultaneous launch for their Medicare Advantage members. With nationwide anxiety remaining at heightened levels, particularly among the Medicare population, we look forward to providing critical behavioral healthcare to these members, especially since many of them have been avoiding or delaying care for chronic conditions, due to fears of being exposed to the COVID-19 virus.”

 

Mr. Peizer continued, “This is our second national plan to roll out our program across their national book of business, and while this agreement was already incorporated into our financial outlook for 2020, it does provide us greater visibility and confidence in our ability to achieve our previously stated financial outlook for the year. We look forward to the honor of serving even more members in the OnTrak-CI program and to leverage our strong results with this health plan into their other books of business.”

 

The Catasys business model scales rapidly to deliver integrated healthcare solutions to the company’s rapidly growing member population. The net enrollment momentum that Catasys saw in April continued through May and through June, and the company is pleased to see health plan partners embracing its whole health approach to behavioral healthcare by awarding Catasys their business. As of today, the company has surpassed 12,000 total enrolled members, up approximately 40% sequentially from 8,600 at the end of Q1, and management expects this national expansion will help further accelerate enrollment in the back half of 2020. Catasys OnTrak™ programs for substance use disorder, depression and anxiety are well aligned to the new environment for delivering quality healthcare, because they are entirely telephonic and staffed by a nationwide virtual network of employee Member Engagement Specialists, Care Coaches and Community Care Coordinators combined with a credentialed, virtualized telehealth network of behavioral health and medical providers.

 

 

Catasys, Inc. Page 2
June 30, 2020  

 

 

About Catasys, Inc.

Catasys, Inc. is a leading AI and telehealth enabled, virtualized outpatient healthcare treatment company, whose mission is to help improve the health and save the lives of as many people as possible. Its Catasys PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who aren’t getting the care they need. By combining predictive analytics with human engagement, Catasys delivers improved member health and validated outcomes and savings to healthcare payers.

 

Catasys’ integrated, technology-enabled OnTrak™ solution, a critical component of the Catasys PRE platform, is designed to treat members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.

 

Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance.

 

OnTrak™ integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The program improves member health and delivers validated cost savings to healthcare payers of more than 50 percent for enrolled members. OnTrak™ is available to members of leading national and regional health plans in 30 states and in Washington, D.C.

 

Learn more at www.catasys.com.

 

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

 

Contact

 

Catasys, Inc.
Ariel Davis

Phone: 310-444-4346

Email:     ariel@catasys.com